| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | stem cell factor receptor binding | 8.56e-06 | 5 | 19 | 2 | GO:0005173 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 6.88e-04 | 41 | 19 | 2 | GO:0030291 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.72e-03 | 65 | 19 | 2 | GO:0004714 | |
| GeneOntologyMolecularFunction | kinase binding | 1.75e-03 | 969 | 19 | 5 | GO:0019900 | |
| GeneOntologyMolecularFunction | protein kinase inhibitor activity | 2.66e-03 | 81 | 19 | 2 | GO:0004860 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.92e-03 | 85 | 19 | 2 | GO:0019199 | |
| GeneOntologyMolecularFunction | kinase inhibitor activity | 2.99e-03 | 86 | 19 | 2 | GO:0019210 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 5.10e-03 | 113 | 19 | 2 | GO:0019208 | |
| GeneOntologyBiologicalProcess | regulation of lens fiber cell differentiation | 6.67e-08 | 10 | 18 | 3 | GO:1902746 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.53e-06 | 730 | 18 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | melanocyte migration | 2.16e-06 | 3 | 18 | 2 | GO:0097324 | |
| GeneOntologyBiologicalProcess | sensory system development | 2.57e-06 | 491 | 18 | 6 | GO:0048880 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 7.23e-06 | 44 | 18 | 3 | GO:0070306 | |
| GeneOntologyBiologicalProcess | negative regulation of lens fiber cell differentiation | 1.08e-05 | 6 | 18 | 2 | GO:1902747 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.01e-05 | 192 | 18 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 2.14e-05 | 195 | 18 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.52e-05 | 426 | 18 | 5 | GO:0043010 | |
| GeneOntologyBiologicalProcess | eye development | 4.46e-05 | 480 | 18 | 5 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 4.59e-05 | 483 | 18 | 5 | GO:0150063 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 4.61e-05 | 815 | 18 | 6 | GO:0043408 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.83e-05 | 850 | 18 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 7.21e-05 | 883 | 18 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 8.28e-05 | 276 | 18 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 9.34e-05 | 103 | 18 | 3 | GO:0002088 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 9.62e-05 | 930 | 18 | 6 | GO:0000165 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA damage response, signal transduction by p53 class mediator | 9.71e-05 | 17 | 18 | 2 | GO:0043517 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.09e-04 | 296 | 18 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | 1.17e-04 | 1421 | 18 | 7 | GO:0019220 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | 1.19e-04 | 1423 | 18 | 7 | GO:0051174 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 1.40e-04 | 611 | 18 | 5 | GO:0045859 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | 1.57e-04 | 1488 | 18 | 7 | GO:0031399 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.77e-04 | 336 | 18 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.82e-04 | 129 | 18 | 3 | GO:0043406 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.91e-04 | 343 | 18 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | fibroblast activation | 1.96e-04 | 24 | 18 | 2 | GO:0072537 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 1.96e-04 | 24 | 18 | 2 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.00e-04 | 347 | 18 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 2.07e-04 | 350 | 18 | 4 | GO:0045860 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 2.22e-04 | 138 | 18 | 3 | GO:0030512 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 2.40e-04 | 686 | 18 | 5 | GO:0043549 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.61e-04 | 372 | 18 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 2.84e-04 | 1133 | 18 | 6 | GO:0001932 | |
| GeneOntologyBiologicalProcess | melanocyte differentiation | 2.88e-04 | 29 | 18 | 2 | GO:0030318 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 3.60e-04 | 405 | 18 | 4 | GO:0033674 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.64e-04 | 1186 | 18 | 6 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.84e-04 | 412 | 18 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 3.97e-04 | 34 | 18 | 2 | GO:0090311 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 3.97e-04 | 34 | 18 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | positive regulation of signal transduction by p53 class mediator | 3.97e-04 | 34 | 18 | 2 | GO:1901798 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 4.24e-04 | 1220 | 18 | 6 | GO:0051093 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 4.35e-04 | 1226 | 18 | 6 | GO:0042325 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.14e-04 | 445 | 18 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 5.16e-04 | 810 | 18 | 5 | GO:0051338 | |
| GeneOntologyBiologicalProcess | pigment cell differentiation | 5.50e-04 | 40 | 18 | 2 | GO:0050931 | |
| GeneOntologyBiologicalProcess | regulation of DNA damage response, signal transduction by p53 class mediator | 5.50e-04 | 40 | 18 | 2 | GO:0043516 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 5.78e-04 | 41 | 18 | 2 | GO:0035025 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 5.93e-04 | 1299 | 18 | 6 | GO:1902533 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 5.93e-04 | 193 | 18 | 3 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 6.02e-04 | 194 | 18 | 3 | GO:0043405 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 6.07e-04 | 42 | 18 | 2 | GO:0045879 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 6.36e-04 | 43 | 18 | 2 | GO:0021955 | |
| GeneOntologyBiologicalProcess | negative regulation of MAPK cascade | 6.68e-04 | 201 | 18 | 3 | GO:0043409 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 6.95e-04 | 482 | 18 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 7.33e-04 | 875 | 18 | 5 | GO:0045596 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 7.39e-04 | 490 | 18 | 4 | GO:0051347 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 7.60e-04 | 47 | 18 | 2 | GO:0006476 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 8.34e-04 | 217 | 18 | 3 | GO:0030856 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.45e-04 | 218 | 18 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | tube development | 8.89e-04 | 1402 | 18 | 6 | GO:0035295 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 9.29e-04 | 52 | 18 | 2 | GO:0010799 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 1.04e-03 | 55 | 18 | 2 | GO:0035886 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial to mesenchymal transition | 1.08e-03 | 56 | 18 | 2 | GO:0010719 | |
| GeneOntologyBiologicalProcess | developmental pigmentation | 1.16e-03 | 58 | 18 | 2 | GO:0048066 | |
| GeneOntologyBiologicalProcess | protein deacylation | 1.16e-03 | 58 | 18 | 2 | GO:0035601 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 1.32e-03 | 62 | 18 | 2 | GO:0001755 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 1.36e-03 | 577 | 18 | 4 | GO:0001667 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 1.36e-03 | 63 | 18 | 2 | GO:0098732 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 1.40e-03 | 64 | 18 | 2 | GO:0090497 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 1.63e-03 | 69 | 18 | 2 | GO:0030857 | |
| HumanPheno | Skin nodule | 2.13e-08 | 132 | 9 | 6 | HP:0200036 | |
| HumanPheno | Neoplasm of the nervous system | 2.23e-07 | 195 | 9 | 6 | HP:0004375 | |
| HumanPheno | Papule | 3.37e-07 | 209 | 9 | 6 | HP:0200034 | |
| HumanPheno | Neoplasm of the central nervous system | 5.54e-06 | 178 | 9 | 5 | HP:0100006 | |
| HumanPheno | Abnormality of skin pigmentation | 5.60e-06 | 561 | 9 | 7 | HP:0001000 | |
| HumanPheno | Localized skin lesion | 6.85e-06 | 897 | 9 | 8 | HP:0011355 | |
| HumanPheno | Neoplasm by anatomical site | 1.16e-05 | 959 | 9 | 8 | HP:0011793 | |
| HumanPheno | Abnormality of pigmentation | 1.17e-05 | 625 | 9 | 7 | HP:0200045 | |
| HumanPheno | Neoplasm by histology | 1.20e-05 | 383 | 9 | 6 | HP:0011792 | |
| HumanPheno | Subcutaneous nodule | 1.33e-05 | 95 | 9 | 4 | HP:0001482 | |
| HumanPheno | Neoplasm | 1.45e-05 | 987 | 9 | 8 | HP:0002664 | |
| HumanPheno | Malignant neoplasm of the central nervous system | 1.57e-05 | 99 | 9 | 4 | HP:0100836 | |
| HumanPheno | Abnormality iris morphology | 2.07e-05 | 680 | 9 | 7 | HP:0000525 | |
| HumanPheno | Posteriorly rotated ears | 3.94e-05 | 470 | 9 | 6 | HP:0000358 | |
| HumanPheno | Downslanted palpebral fissures | 5.44e-05 | 497 | 9 | 6 | HP:0000494 | |
| HumanPheno | Pulmonic stenosis | 5.85e-05 | 138 | 9 | 4 | HP:0001642 | |
| HumanPheno | Pointed chin | 5.85e-05 | 138 | 9 | 4 | HP:0000307 | |
| HumanPheno | Abnormal bleeding | 8.49e-05 | 537 | 9 | 6 | HP:0001892 | |
| HumanPheno | Abnormal pulmonary valve physiology | 1.12e-04 | 163 | 9 | 4 | HP:0031654 | |
| HumanPheno | Melanocytic nevus | 1.80e-04 | 68 | 9 | 3 | HP:0000995 | |
| HumanPheno | Leukemia | 1.92e-04 | 187 | 9 | 4 | HP:0001909 | |
| HumanPheno | Neoplasm of the peripheral nervous system | 1.97e-04 | 70 | 9 | 3 | HP:0100007 | |
| HumanPheno | Soft tissue neoplasm | 2.14e-04 | 13 | 9 | 2 | HP:0031459 | |
| HumanPheno | Abnormal uvea morphology | 2.16e-04 | 965 | 9 | 7 | HP:0000553 | |
| HumanPheno | Abnormal eyelid morphology | 2.28e-04 | 1408 | 9 | 8 | HP:0000492 | |
| HumanPheno | Abnormal pulmonary valve morphology | 2.39e-04 | 198 | 9 | 4 | HP:0001641 | |
| HumanPheno | Abnormality of coagulation | 2.45e-04 | 647 | 9 | 6 | HP:0001928 | |
| HumanPheno | Abnormal anterior eye segment morphology | 2.86e-04 | 1450 | 9 | 8 | HP:0004328 | |
| HumanPheno | Abnormality of the chin | 3.13e-04 | 409 | 9 | 5 | HP:0000306 | |
| HumanPheno | Myeloproliferative disorder | 3.29e-04 | 16 | 9 | 2 | HP:0005547 | |
| HumanPheno | Neuroepithelial neoplasm | 4.43e-04 | 92 | 9 | 3 | HP:0030063 | |
| HumanPheno | Abnormal hand morphology | 4.60e-04 | 1082 | 9 | 7 | HP:0005922 | |
| HumanPheno | Neurofibroma | 4.67e-04 | 19 | 9 | 2 | HP:0001067 | |
| HumanPheno | Abnormality of the philtrum | 4.70e-04 | 726 | 9 | 6 | HP:0000288 | |
| HumanPheno | Neuroectodermal neoplasm | 4.72e-04 | 94 | 9 | 3 | HP:0030061 | |
| HumanPheno | Nervous tissue neoplasm | 4.72e-04 | 94 | 9 | 3 | HP:0030060 | |
| HumanPheno | Abnormality of the inner ear | 5.19e-04 | 1102 | 9 | 7 | HP:0000359 | |
| HumanPheno | Slanting of the palpebral fissure | 5.19e-04 | 739 | 9 | 6 | HP:0200006 | |
| HumanPheno | Ptosis | 5.81e-04 | 754 | 9 | 6 | HP:0000508 | |
| HumanPheno | Abnormality of globe location | 5.83e-04 | 1122 | 9 | 7 | HP:0100886 | |
| HumanPheno | Chiari malformation | 6.90e-04 | 107 | 9 | 3 | HP:0002308 | |
| HumanPheno | Abnormal nasal dorsum morphology | 7.02e-04 | 262 | 9 | 4 | HP:0011119 | |
| HumanPheno | Ectopia pupillae | 7.51e-04 | 24 | 9 | 2 | HP:0009918 | |
| HumanPheno | Abnormality of blood circulation | 7.90e-04 | 498 | 9 | 5 | HP:0011028 | |
| HumanPheno | Wide nasal bridge | 8.67e-04 | 508 | 9 | 5 | HP:0000431 | |
| HumanPheno | Xanthelasma | 8.82e-04 | 26 | 9 | 2 | HP:0001114 | |
| HumanPheno | Anterior bulging of the globe | 9.41e-04 | 283 | 9 | 4 | HP:0000644 | |
| HumanPheno | Proptosis | 9.41e-04 | 283 | 9 | 4 | HP:0000520 | |
| HumanPheno | Cyst of the eyelid | 9.52e-04 | 27 | 9 | 2 | HP:0010604 | |
| HumanPheno | Narrow nose | 1.02e-03 | 28 | 9 | 2 | HP:0000460 | |
| HumanPheno | Mitral valve prolapse | 1.04e-03 | 123 | 9 | 3 | HP:0001634 | |
| HumanPheno | Midface retrusion | 1.05e-03 | 291 | 9 | 4 | HP:0011800 | |
| HumanPheno | Fibroma | 1.06e-03 | 124 | 9 | 3 | HP:0010614 | |
| HumanPheno | Nodular changes affecting the eyelids | 1.10e-03 | 29 | 9 | 2 | HP:0010732 | |
| HumanPheno | Fibrous tissue neoplasm | 1.11e-03 | 126 | 9 | 3 | HP:0012316 | |
| HumanPheno | Abnormality of globe location or size | 1.15e-03 | 1246 | 9 | 7 | HP:0000489 | |
| HumanPheno | Myeloid leukemia | 1.26e-03 | 31 | 9 | 2 | HP:0012324 | |
| HumanPheno | Abnormal pulmonary artery morphology | 1.30e-03 | 133 | 9 | 3 | HP:0030966 | |
| HumanPheno | Abnormality of the palpebral fissures | 1.37e-03 | 880 | 9 | 6 | HP:0008050 | |
| HumanPheno | Abnormal pupil morphology | 1.39e-03 | 136 | 9 | 3 | HP:0000615 | |
| HumanPheno | Thick lower lip vermilion | 1.39e-03 | 136 | 9 | 3 | HP:0000179 | |
| HumanPheno | Pectus excavatum | 1.55e-03 | 323 | 9 | 4 | HP:0000767 | |
| HumanPheno | Reduced bone mineral density | 1.58e-03 | 578 | 9 | 5 | HP:0004349 | |
| HumanPheno | Aplasia/Hypoplasia of the abdominal wall musculature | 1.69e-03 | 36 | 9 | 2 | HP:0010318 | |
| HumanPheno | Shallow orbits | 1.69e-03 | 36 | 9 | 2 | HP:0000586 | |
| HumanPheno | Abnormal heart valve morphology | 1.71e-03 | 588 | 9 | 5 | HP:0001654 | |
| HumanPheno | Abnormal mitral valve morphology | 1.71e-03 | 146 | 9 | 3 | HP:0031477 | |
| HumanPheno | Vascular skin abnormality | 1.77e-03 | 593 | 9 | 5 | HP:0011276 | |
| HumanPheno | Abnormal enteric ganglion morphology | 1.85e-03 | 150 | 9 | 3 | HP:0004362 | |
| HumanPheno | Aganglionic megacolon | 1.85e-03 | 150 | 9 | 3 | HP:0002251 | |
| HumanPheno | Megacolon | 1.85e-03 | 150 | 9 | 3 | HP:6000852 | |
| HumanPheno | Abnormal autonomic nervous system morphology | 1.88e-03 | 151 | 9 | 3 | HP:0012331 | |
| HumanPheno | Abnormal enteric nervous system morphology | 1.88e-03 | 151 | 9 | 3 | HP:0025028 | |
| HumanPheno | Abnormal diaphysis morphology | 1.94e-03 | 343 | 9 | 4 | HP:0000940 | |
| HumanPheno | Short foot | 1.95e-03 | 153 | 9 | 3 | HP:0001773 | |
| HumanPheno | Short feet | 1.95e-03 | 153 | 9 | 3 | HP:0001766 | |
| HumanPheno | Small feet | 1.95e-03 | 153 | 9 | 3 | HP:0001764 | |
| HumanPheno | Cardiovascular calcification | 1.99e-03 | 39 | 9 | 2 | HP:0011915 | |
| HumanPheno | Abnormal morphology of bony orbit of skull | 1.99e-03 | 39 | 9 | 2 | HP:3000030 | |
| HumanPheno | Xanthomatosis | 1.99e-03 | 39 | 9 | 2 | HP:0000991 | |
| HumanPheno | Abnormal location of ears | 2.02e-03 | 945 | 9 | 6 | HP:0000357 | |
| HumanPheno | Abdominal distention | 2.03e-03 | 155 | 9 | 3 | HP:0003270 | |
| HumanPheno | Prominent lips | 2.07e-03 | 156 | 9 | 3 | HP:0000184 | |
| MousePheno | increased mast cell number | 3.92e-07 | 12 | 18 | 3 | MP:0000324 | |
| MousePheno | abnormal mast cell number | 5.14e-06 | 27 | 18 | 3 | MP:0020203 | |
| MousePheno | abnormal neural crest cell morphology | 7.12e-06 | 30 | 18 | 3 | MP:0009845 | |
| MousePheno | abnormal multipotent stem cell morphology | 7.88e-06 | 31 | 18 | 3 | MP:0002400 | |
| MousePheno | abnormal neural crest morphology | 8.69e-06 | 32 | 18 | 3 | MP:0009846 | |
| MousePheno | abnormal neural crest cell migration | 1.05e-05 | 34 | 18 | 3 | MP:0002950 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 1.50e-05 | 700 | 18 | 7 | MP:0011098 | |
| MousePheno | abnormal mast cell morphology | 1.99e-05 | 42 | 18 | 3 | MP:0000359 | |
| MousePheno | abnormal pluripotent precursor cell morphology | 1.99e-05 | 42 | 18 | 3 | MP:0002399 | |
| MousePheno | abnormal neural crest cell physiology | 2.14e-05 | 43 | 18 | 3 | MP:0012745 | |
| MousePheno | embryonic lethality during organogenesis | 6.40e-05 | 876 | 18 | 7 | MP:0006207 | |
| MousePheno | decreased neural crest cell number | 1.21e-04 | 13 | 18 | 2 | MP:0009843 | |
| MousePheno | increased mast cell degranulation | 1.41e-04 | 14 | 18 | 2 | MP:0008764 | |
| MousePheno | craniofacial phenotype | 1.50e-04 | 1372 | 18 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.50e-04 | 1372 | 18 | 8 | MP:0000428 | |
| MousePheno | lethality throughout fetal growth and development | 1.75e-04 | 435 | 18 | 5 | MP:0006208 | |
| MousePheno | abnormal blood coagulation | 2.15e-04 | 240 | 18 | 4 | MP:0002551 | |
| MousePheno | abnormal hemostasis | 2.21e-04 | 242 | 18 | 4 | MP:0009676 | |
| MousePheno | abnormal skin morphology | 2.27e-04 | 1455 | 18 | 8 | MP:0002060 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 2.37e-04 | 18 | 18 | 2 | MP:0011395 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 3.04e-04 | 263 | 18 | 4 | MP:0011099 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 3.27e-04 | 268 | 18 | 4 | MP:0011108 | |
| MousePheno | limbs/digits/tail phenotype | 6.15e-04 | 1258 | 18 | 7 | MP:0005371 | |
| MousePheno | abnormal enteric nervous system morphology | 7.12e-04 | 31 | 18 | 2 | MP:0001044 | |
| MousePheno | abnormal mast cell degranulation | 8.57e-04 | 34 | 18 | 2 | MP:0008763 | |
| MousePheno | aneurysm | 9.09e-04 | 35 | 18 | 2 | MP:0003279 | |
| MousePheno | abnormal fetal cardiomyocyte morphology | 9.09e-04 | 35 | 18 | 2 | MP:0008788 | |
| MousePheno | disorganized myocardium | 1.19e-03 | 40 | 18 | 2 | MP:0002190 | |
| MousePheno | decreased litter size | 1.22e-03 | 380 | 18 | 4 | MP:0001935 | |
| MousePheno | belly spot | 1.25e-03 | 41 | 18 | 2 | MP:0000373 | |
| MousePheno | impaired wound healing | 1.31e-03 | 42 | 18 | 2 | MP:0001792 | |
| MousePheno | abnormal respiratory function | 1.46e-03 | 399 | 18 | 4 | MP:0002327 | |
| MousePheno | abnormal litter size | 1.46e-03 | 399 | 18 | 4 | MP:0001933 | |
| MousePheno | increased megakaryocyte cell number | 1.50e-03 | 45 | 18 | 2 | MP:0008254 | |
| MousePheno | dilated heart right ventricle | 1.57e-03 | 46 | 18 | 2 | MP:0002754 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.61e-03 | 410 | 18 | 4 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.61e-03 | 410 | 18 | 4 | MP:0011102 | |
| MousePheno | increased mean platelet volume | 1.63e-03 | 186 | 18 | 3 | MP:0002599 | |
| MousePheno | abnormal exocytosis | 1.71e-03 | 48 | 18 | 2 | MP:0020848 | |
| MousePheno | increased tumor growth/size | 1.71e-03 | 48 | 18 | 2 | MP:0003721 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 1.71e-03 | 48 | 18 | 2 | MP:0003567 | |
| MousePheno | dilated heart atrium | 1.78e-03 | 49 | 18 | 2 | MP:0003140 | |
| MousePheno | white spotting | 1.85e-03 | 50 | 18 | 2 | MP:0002938 | |
| MousePheno | abnormal airway responsiveness | 1.92e-03 | 51 | 18 | 2 | MP:0002334 | |
| MousePheno | abnormal bronchial provocation | 2.00e-03 | 52 | 18 | 2 | MP:0002330 | |
| MousePheno | abnormal lung volume | 2.23e-03 | 55 | 18 | 2 | MP:0001942 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 2.23e-03 | 55 | 18 | 2 | MP:0011390 | |
| MousePheno | abnormal neuron number | 2.38e-03 | 456 | 18 | 4 | MP:0008946 | |
| MousePheno | abnormal embryonic hematopoiesis | 2.48e-03 | 58 | 18 | 2 | MP:0003396 | |
| MousePheno | abnormal skin appearance | 2.71e-03 | 473 | 18 | 4 | MP:0009931 | |
| MousePheno | abnormal heart size | 2.73e-03 | 1180 | 18 | 6 | MP:0005406 | |
| MousePheno | abnormal fibroblast apoptosis | 2.83e-03 | 62 | 18 | 2 | MP:0013500 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 3.06e-03 | 489 | 18 | 4 | MP:0010630 | |
| MousePheno | blood vessel congestion | 3.10e-03 | 65 | 18 | 2 | MP:0000255 | |
| MousePheno | abnormal platelet volume | 3.18e-03 | 235 | 18 | 3 | MP:0002586 | |
| MousePheno | abnormal fluid regulation | 3.20e-03 | 826 | 18 | 5 | MP:0001784 | |
| MousePheno | abnormal myocardium compact layer morphology | 3.30e-03 | 67 | 18 | 2 | MP:0004056 | |
| MousePheno | abnormal mast cell physiology | 3.30e-03 | 67 | 18 | 2 | MP:0002423 | |
| MousePheno | pallor | 3.33e-03 | 239 | 18 | 3 | MP:0003717 | |
| MousePheno | abnormal cell migration | 3.34e-03 | 501 | 18 | 4 | MP:0003091 | |
| MousePheno | abnormal vascular permeability | 3.39e-03 | 68 | 18 | 2 | MP:0001619 | |
| MousePheno | dilated vasculature | 3.59e-03 | 70 | 18 | 2 | MP:0004938 | |
| MousePheno | ventricle myocardium hypoplasia | 3.69e-03 | 71 | 18 | 2 | MP:0010502 | |
| MousePheno | abnormal nervous system development | 3.76e-03 | 1257 | 18 | 6 | MP:0003861 | |
| Domain | KBD | 2.94e-06 | 3 | 19 | 2 | PS51488 | |
| Domain | KBD | 2.94e-06 | 3 | 19 | 2 | IPR023337 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 1.47e-05 | 6 | 19 | 2 | IPR016243 | |
| Domain | SPR | 2.05e-05 | 7 | 19 | 2 | PS51227 | |
| Domain | Sprouty | 2.05e-05 | 7 | 19 | 2 | IPR007875 | |
| Domain | Sprouty | 2.05e-05 | 7 | 19 | 2 | PF05210 | |
| Domain | RECEPTOR_TYR_KIN_III | 2.74e-05 | 8 | 19 | 2 | PS00240 | |
| Domain | Tyr_kinase_rcpt_3_CS | 2.74e-05 | 8 | 19 | 2 | IPR001824 | |
| Domain | WH1 | 5.36e-05 | 11 | 19 | 2 | SM00461 | |
| Domain | WH1 | 5.36e-05 | 11 | 19 | 2 | PF00568 | |
| Domain | WH1/EVH1_dom | 5.36e-05 | 11 | 19 | 2 | IPR000697 | |
| Domain | WH1 | 7.60e-05 | 13 | 19 | 2 | PS50229 | |
| Domain | - | 5.71e-04 | 391 | 19 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 7.88e-04 | 426 | 19 | 4 | IPR011993 | |
| Domain | TyrKc | 3.56e-03 | 88 | 19 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.56e-03 | 88 | 19 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.31e-03 | 97 | 19 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.31e-03 | 97 | 19 | 2 | IPR008266 | |
| Domain | Pkinase_Tyr | 7.50e-03 | 129 | 19 | 2 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.54e-03 | 138 | 19 | 2 | IPR001245 | |
| Domain | Immunoglobulin | 1.57e-02 | 190 | 19 | 2 | IPR013151 | |
| Domain | ig | 1.57e-02 | 190 | 19 | 2 | PF00047 | |
| Pathway | WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA | 1.35e-06 | 20 | 16 | 3 | M39381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 1.81e-05 | 6 | 16 | 2 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 2.53e-05 | 7 | 16 | 2 | M29717 | |
| Pathway | PID_KIT_PATHWAY | 2.56e-05 | 52 | 16 | 3 | M231 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 6.54e-05 | 71 | 16 | 3 | MM15947 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 9.35e-05 | 13 | 16 | 2 | M27540 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 9.35e-05 | 13 | 16 | 2 | MM15262 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 3.57e-04 | 25 | 16 | 2 | M47934 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 3.73e-04 | 318 | 16 | 4 | MM15278 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 4.15e-04 | 327 | 16 | 4 | M27565 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.01e-03 | 42 | 16 | 2 | M48018 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.04e-03 | 418 | 16 | 4 | MM15587 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.06e-03 | 43 | 16 | 2 | M53 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 1.43e-03 | 50 | 16 | 2 | MM15255 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 1.54e-03 | 464 | 16 | 4 | M27547 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 1.55e-03 | 52 | 16 | 2 | M27530 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.99e-03 | 59 | 16 | 2 | M46460 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.99e-03 | 59 | 16 | 2 | M39886 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 2.48e-03 | 66 | 16 | 2 | MM15261 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.54e-03 | 532 | 16 | 4 | M27870 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 2.63e-03 | 68 | 16 | 2 | M27539 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.79e-03 | 70 | 16 | 2 | M938 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 3.36e-03 | 77 | 16 | 2 | MM14722 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 3.80e-03 | 82 | 16 | 2 | M27626 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 3.90e-03 | 83 | 16 | 2 | M27163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 3.90e-03 | 83 | 16 | 2 | M47961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 4.47e-03 | 89 | 16 | 2 | M47963 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 4.47e-03 | 89 | 16 | 2 | M1090 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 4.76e-03 | 92 | 16 | 2 | M47927 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 5.39e-03 | 98 | 16 | 2 | M39830 | |
| Pubmed | Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation. | 5.53e-10 | 4 | 19 | 3 | 12646235 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11493923 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 23016555 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25690936 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 16652141 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 14871970 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15465815 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19280218 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 19028276 | ||
| Pubmed | The role of mast cells in the development of skin fibrosis in tight-skin mutant mice. | 2.83e-07 | 2 | 19 | 2 | 7704626 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 20197394 | ||
| Pubmed | Distinct requirements for the Sprouty domain for functional activity of Spred proteins. | 2.83e-07 | 2 | 19 | 2 | 15683364 | |
| Pubmed | Single-cell transcriptomic landscapes of the otic neuronal lineage at multiple early embryonic ages. | 5.56e-07 | 30 | 19 | 3 | 35320729 | |
| Pubmed | 6.79e-07 | 32 | 19 | 3 | 16516881 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 21364986 | ||
| Pubmed | Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas. | 8.48e-07 | 3 | 19 | 2 | 17298867 | |
| Pubmed | Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress. | 8.48e-07 | 3 | 19 | 2 | 29706577 | |
| Pubmed | Expression and subcellular localization of Spred proteins in mouse and human tissues. | 8.48e-07 | 3 | 19 | 2 | 15580519 | |
| Pubmed | Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors. | 8.48e-07 | 3 | 19 | 2 | 18492696 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 15791568 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 15184877 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 26483058 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 19302534 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 19636022 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 26075267 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 19120036 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 14745431 | ||
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 20736167 | ||
| Pubmed | The negative regulatory Spred1 and Spred2 proteins are required for lens and eye morphogenesis. | 4.24e-06 | 6 | 19 | 2 | 31923414 | |
| Pubmed | Negative regulation of lens fiber cell differentiation by RTK antagonists Spry and Spred. | 4.24e-06 | 6 | 19 | 2 | 29501879 | |
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 21355089 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 38391903 | ||
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 7873879 | ||
| Pubmed | Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation. | 4.24e-06 | 6 | 19 | 2 | 14981116 | |
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 25576668 | ||
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 4.41e-06 | 207 | 19 | 4 | 26238476 | |
| Pubmed | 7.90e-06 | 8 | 19 | 2 | 18194151 | ||
| Pubmed | 7.90e-06 | 8 | 19 | 2 | 17438136 | ||
| Pubmed | PDGFRβ+ cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny. | 7.90e-06 | 8 | 19 | 2 | 35858557 | |
| Pubmed | Abl family kinases regulate endothelial barrier function in vitro and in mice. | 7.90e-06 | 8 | 19 | 2 | 24367707 | |
| Pubmed | A high-resolution molecular atlas of the fetal mouse lower urogenital tract. | 9.10e-06 | 75 | 19 | 3 | 21905163 | |
| Pubmed | CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. | 1.02e-05 | 9 | 19 | 2 | 12177062 | |
| Pubmed | Genetic Tracing Identifies Early Segregation of the Cardiomyocyte and Nonmyocyte Lineages. | 1.27e-05 | 10 | 19 | 2 | 31185811 | |
| Pubmed | 1.86e-05 | 12 | 19 | 2 | 17974561 | ||
| Pubmed | 1.86e-05 | 12 | 19 | 2 | 36779913 | ||
| Pubmed | 2.20e-05 | 13 | 19 | 2 | 15857912 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 1912584 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 27370713 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 23789091 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 26362256 | ||
| Pubmed | 3.38e-05 | 16 | 19 | 2 | 17699610 | ||
| Pubmed | Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. | 3.38e-05 | 16 | 19 | 2 | 10022833 | |
| Pubmed | Fine mapping of the CELIAC2 locus on chromosome 5q31-q33 in the Finnish and Hungarian populations. | 3.83e-05 | 17 | 19 | 2 | 19845895 | |
| Pubmed | Hirschsprung Disease Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.30e-05 | 18 | 19 | 2 | 20301612 | |
| Pubmed | 4.30e-05 | 18 | 19 | 2 | 15741322 | ||
| Pubmed | Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. | 4.30e-05 | 18 | 19 | 2 | 16790476 | |
| Pubmed | 4.51e-05 | 1285 | 19 | 6 | 35914814 | ||
| Pubmed | Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo. | 4.81e-05 | 19 | 19 | 2 | 28111199 | |
| Pubmed | 4.81e-05 | 19 | 19 | 2 | 17507395 | ||
| Pubmed | 4.81e-05 | 19 | 19 | 2 | 29196262 | ||
| Pubmed | Mesenchymal cells are required for functional development of thymic epithelial cells. | 5.90e-05 | 21 | 19 | 2 | 17625108 | |
| Pubmed | Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromes. | 5.90e-05 | 21 | 19 | 2 | 32452519 | |
| Pubmed | Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling. | 6.49e-05 | 22 | 19 | 2 | 22387002 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 6.49e-05 | 22 | 19 | 2 | 26886794 | |
| Pubmed | Fgf9 signalling stimulates Spred and Sprouty expression in embryonic mouse pancreas mesenchyme. | 7.10e-05 | 23 | 19 | 2 | 20934536 | |
| Pubmed | 7.10e-05 | 23 | 19 | 2 | 23946446 | ||
| Pubmed | 7.75e-05 | 24 | 19 | 2 | 30348676 | ||
| Pubmed | 7.75e-05 | 24 | 19 | 2 | 17131407 | ||
| Pubmed | Specification of CNS macrophage subsets occurs postnatally in defined niches. | 9.84e-05 | 27 | 19 | 2 | 35444273 | |
| Pubmed | 9.84e-05 | 27 | 19 | 2 | 31257105 | ||
| Pubmed | 1.06e-04 | 28 | 19 | 2 | 18593464 | ||
| Pubmed | 1.30e-04 | 31 | 19 | 2 | 36445780 | ||
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 1.39e-04 | 32 | 19 | 2 | 7542761 | |
| Pubmed | 2.35e-04 | 1084 | 19 | 5 | 11544199 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 3.01e-04 | 47 | 19 | 2 | 19167335 | |
| Pubmed | Primary Cilia are Required for Cell-Type Determination and Angiogenesis in Pituitary Development. | 3.01e-04 | 47 | 19 | 2 | 39001875 | |
| Pubmed | 3.14e-04 | 48 | 19 | 2 | 35905011 | ||
| Pubmed | 3.14e-04 | 48 | 19 | 2 | 16632597 | ||
| Pubmed | 3.41e-04 | 50 | 19 | 2 | 37974198 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 3.69e-04 | 52 | 19 | 2 | 30389913 | |
| Pubmed | 3.69e-04 | 52 | 19 | 2 | 8288218 | ||
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 3.98e-04 | 54 | 19 | 2 | 17151600 | |
| Pubmed | 4.00e-04 | 268 | 19 | 3 | 33640491 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.69e-04 | 283 | 19 | 3 | 30585729 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 5.03e-04 | 80 | 19 | 2 | chr5q32 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.11e-04 | 40 | 12 | 2 | 321 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.16e-03 | 181 | 12 | 2 | 694 | |
| GeneFamily | Immunoglobulin like domain containing | 6.97e-03 | 193 | 12 | 2 | 594 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.05e-02 | 718 | 12 | 3 | 28 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP | 1.17e-05 | 200 | 19 | 4 | M4570 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 1.63e-05 | 465 | 19 | 5 | M2466 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.16e-05 | 493 | 19 | 5 | M19391 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 2.16e-05 | 493 | 19 | 5 | MM1079 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 7.58e-05 | 323 | 19 | 4 | M9150 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 9.39e-05 | 20 | 19 | 2 | M48357 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 9.70e-05 | 125 | 19 | 3 | M38988 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.00e-04 | 681 | 19 | 5 | M39175 | |
| Coexpression | BROWNE_HCMV_INFECTION_24HR_DN | 1.51e-04 | 145 | 19 | 3 | M14098 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.07e-04 | 795 | 19 | 5 | M39050 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 2.22e-04 | 807 | 19 | 5 | M16651 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 2.42e-04 | 822 | 19 | 5 | M6782 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 2.58e-04 | 174 | 19 | 3 | M6881 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 2.85e-04 | 180 | 19 | 3 | M6878 | |
| Coexpression | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP | 3.09e-04 | 36 | 19 | 2 | M2047 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP | 3.49e-04 | 193 | 19 | 3 | M6130 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | 3.65e-04 | 899 | 19 | 5 | M2242 | |
| Coexpression | GSE13229_MATURE_VS_INTMATURE_NKCELL_DN | 3.76e-04 | 198 | 19 | 3 | M3216 | |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_UP | 3.82e-04 | 199 | 19 | 3 | M4507 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 3.88e-04 | 200 | 19 | 3 | M7478 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 3.88e-04 | 200 | 19 | 3 | M7019 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 3.88e-04 | 200 | 19 | 3 | M6095 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 3.88e-04 | 200 | 19 | 3 | M6480 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN | 3.88e-04 | 200 | 19 | 3 | M7822 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN | 3.88e-04 | 200 | 19 | 3 | M4334 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 3.99e-04 | 202 | 19 | 3 | M38982 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 4.22e-04 | 206 | 19 | 3 | M14134 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | 4.27e-04 | 930 | 19 | 5 | MM893 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 4.89e-04 | 526 | 19 | 4 | M2520 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.97e-04 | 50 | 19 | 2 | M1259 | |
| Coexpression | ZHOU_TNF_SIGNALING_4HR | 5.97e-04 | 50 | 19 | 2 | M1520 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 6.46e-04 | 52 | 19 | 2 | MM1118 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 6.96e-04 | 1035 | 19 | 5 | M9898 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 7.24e-04 | 584 | 19 | 4 | MM1080 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN | 7.95e-04 | 256 | 19 | 3 | M41152 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.23e-06 | 107 | 19 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 1.76e-04 | 124 | 19 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.80e-04 | 125 | 19 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.02e-04 | 130 | 19 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 2.63e-04 | 27 | 19 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 2.90e-04 | 147 | 19 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.96e-04 | 148 | 19 | 3 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.13e-04 | 379 | 19 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 3.46e-04 | 156 | 19 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 3.78e-04 | 734 | 19 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 4.07e-04 | 165 | 19 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.29e-04 | 168 | 19 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 4.46e-04 | 416 | 19 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 4.68e-04 | 769 | 19 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.69e-04 | 36 | 19 | 2 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 4.70e-04 | 422 | 19 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 4.79e-04 | 773 | 19 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 4.91e-04 | 777 | 19 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 4.96e-04 | 37 | 19 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 5.42e-04 | 182 | 19 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | 6.17e-04 | 817 | 19 | 5 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 6.21e-04 | 818 | 19 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.24e-04 | 191 | 19 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 7.24e-04 | 846 | 19 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 7.77e-04 | 206 | 19 | 3 | JC_fibro_500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 7.88e-04 | 207 | 19 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 8.30e-04 | 872 | 19 | 5 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.33e-04 | 211 | 19 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.06e-03 | 54 | 19 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 1.26e-03 | 59 | 19 | 2 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.76e-07 | 178 | 19 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 178 | 19 | 4 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.34e-06 | 198 | 19 | 4 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 19 | 4 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 19 | 4 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 19 | 4 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 137 | 19 | 3 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-05 | 137 | 19 | 3 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 142 | 19 | 3 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 145 | 19 | 3 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 148 | 19 | 3 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 151 | 19 | 3 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.33e-05 | 163 | 19 | 3 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 167 | 19 | 3 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 168 | 19 | 3 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | control-Myeloid-Mast_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.09e-05 | 172 | 19 | 3 | c1c99e6732234a6649a79610e99390db0c8f19b0 | |
| ToppCell | NS-control-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-05 | 174 | 19 | 3 | 2d1f5c17b1551f32f49618ec1bf68eafbfd02ace | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-05 | 175 | 19 | 3 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-05 | 175 | 19 | 3 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-05 | 176 | 19 | 3 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.45e-05 | 176 | 19 | 3 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.63e-05 | 178 | 19 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-05 | 182 | 19 | 3 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-05 | 182 | 19 | 3 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 183 | 19 | 3 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 183 | 19 | 3 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 183 | 19 | 3 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-05 | 184 | 19 | 3 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-05 | 184 | 19 | 3 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-05 | 184 | 19 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 185 | 19 | 3 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 186 | 19 | 3 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.42e-05 | 186 | 19 | 3 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.42e-05 | 186 | 19 | 3 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.42e-05 | 186 | 19 | 3 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.42e-05 | 186 | 19 | 3 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-05 | 186 | 19 | 3 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.62e-05 | 188 | 19 | 3 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 188 | 19 | 3 | da862ea3c74f42d0dbae38b09211a45c593d477e | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 6.62e-05 | 188 | 19 | 3 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 188 | 19 | 3 | b82a7667ef74a05e8bc744f6c090a7cc7b8efe32 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 188 | 19 | 3 | 19672d284fe89c9c3c7697514ca1f659329c34f4 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.62e-05 | 188 | 19 | 3 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.73e-05 | 189 | 19 | 3 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 189 | 19 | 3 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 189 | 19 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 189 | 19 | 3 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 189 | 19 | 3 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 189 | 19 | 3 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 189 | 19 | 3 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.73e-05 | 189 | 19 | 3 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 189 | 19 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 189 | 19 | 3 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 190 | 19 | 3 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 190 | 19 | 3 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 190 | 19 | 3 | 6847afca73e1b76c2e86187ccb1a164aefd8f17b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 190 | 19 | 3 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 190 | 19 | 3 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.94e-05 | 191 | 19 | 3 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.94e-05 | 191 | 19 | 3 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 191 | 19 | 3 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 7.05e-05 | 192 | 19 | 3 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 7.05e-05 | 192 | 19 | 3 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | Endothelial-A|World / shred on cell class and cell subclass (v4) | 7.05e-05 | 192 | 19 | 3 | 9919cdc0ce833894525dba429f251ea1b094fbd8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-05 | 192 | 19 | 3 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-05 | 193 | 19 | 3 | 634fdd157cd1efeebf6ecc810bc45e138331451a | |
| ToppCell | E15.5-Mesenchymal|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.16e-05 | 193 | 19 | 3 | 22a9f5b61f197757f72840b9cb849cdb20430e72 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-05 | 193 | 19 | 3 | ce5c3ab79900aa6f394c894267340167009c6149 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-05 | 193 | 19 | 3 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.16e-05 | 193 | 19 | 3 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| Computational | Genes in the cancer module 200. | 6.25e-04 | 27 | 15 | 2 | MODULE_200 | |
| Computational | Genes in the cancer module 80. | 8.80e-04 | 32 | 15 | 2 | MODULE_80 | |
| Computational | Developmental processes. | 9.42e-04 | 333 | 15 | 4 | MODULE_220 | |
| Computational | Genes in the cancer module 51. | 1.11e-03 | 36 | 15 | 2 | MODULE_51 | |
| Drug | nitrofen | 1.21e-06 | 237 | 19 | 5 | ctd:C007350 | |
| Drug | CT52923 | 3.95e-06 | 4 | 19 | 2 | ctd:C461979 | |
| Drug | lissamine | 6.39e-06 | 44 | 19 | 3 | CID005359521 | |
| Drug | orantinib | 9.88e-06 | 6 | 19 | 2 | ctd:C412603 | |
| Drug | Sorafenib | 1.38e-05 | 7 | 19 | 2 | DB00398 | |
| Drug | Sunitinib | 1.84e-05 | 8 | 19 | 2 | DB01268 | |
| Drug | Imatinib | 1.84e-05 | 8 | 19 | 2 | DB00619 | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 5448_UP | |
| Drug | Dasatinib | 2.96e-05 | 10 | 19 | 2 | DB01254 | |
| Drug | SU11652 | 3.61e-05 | 11 | 19 | 2 | CID005329103 | |
| Drug | pazopanib | 4.33e-05 | 12 | 19 | 2 | ctd:C516667 | |
| Drug | chromium oxide | 5.12e-05 | 13 | 19 | 2 | CID000517276 | |
| Drug | tandutinib | 6.88e-05 | 15 | 19 | 2 | CID003038522 | |
| Drug | OPC-18790 | 1.00e-04 | 18 | 19 | 2 | CID000060790 | |
| Drug | Epoxy resin | 1.37e-04 | 21 | 19 | 2 | CID000169944 | |
| Drug | 1,3,8-triazanaphthalene | 1.80e-04 | 24 | 19 | 2 | CID000582898 | |
| Drug | everolimus | 1.88e-04 | 136 | 19 | 3 | CID006442177 | |
| Drug | sorafenib | 2.46e-04 | 149 | 19 | 3 | ctd:C471405 | |
| Drug | trenbolone acetate | 2.64e-04 | 29 | 19 | 2 | CID000066359 | |
| Drug | Dichlorodiphenyldichloroethane | 2.64e-04 | 29 | 19 | 2 | ctd:D003632 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 3.02e-04 | 31 | 19 | 2 | ctd:C577942 | |
| Drug | Endrin | 3.22e-04 | 32 | 19 | 2 | ctd:D004732 | |
| Drug | beta-tyrosine | 3.86e-04 | 35 | 19 | 2 | CID000440311 | |
| Drug | aminopyrimidine | 3.86e-04 | 35 | 19 | 2 | CID000007978 | |
| Drug | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | 4.09e-04 | 36 | 19 | 2 | ctd:C054919 | |
| Drug | trans-retinol acetate | 4.09e-04 | 36 | 19 | 2 | CID000005057 | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.80e-04 | 187 | 19 | 3 | 7368_UP | |
| Drug | Ni-Fe active center | 4.80e-04 | 39 | 19 | 2 | CID005195770 | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.95e-04 | 189 | 19 | 3 | 4688_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 4322_UP | |
| Drug | mM Q | 5.31e-04 | 41 | 19 | 2 | CID000445446 | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 5752_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 5791_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 4492_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2895_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 5582_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 5052_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 4250_UP | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 3796_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 4307_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2720_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 6099_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2463_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4667_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5615_UP | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5392_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 7232_UP | |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 3289_UP | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 5057_DN | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2187_UP | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; PC3; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 4076_UP | |
| Drug | zoxazolamine | 6.11e-04 | 44 | 19 | 2 | CID000006103 | |
| Drug | axitinib | 6.39e-04 | 45 | 19 | 2 | CID006450551 | |
| Drug | GSK1210151A | 8.53e-04 | 52 | 19 | 2 | ctd:C568713 | |
| Disease | Gastrointestinal Stromal Sarcoma | 4.17e-04 | 47 | 19 | 2 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 4.72e-04 | 50 | 19 | 2 | C0238198 | |
| Disease | Malignant neoplasm of breast | 4.80e-04 | 1074 | 19 | 5 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDQSDSESDCSMDTS | 486 | Q9NR81 | |
| MDAETDECMDYTGCS | 1346 | Q86V15 | |
| GYDEDSMDSETSSMA | 436 | Q96AA8 | |
| ESSCSDSTNEYMDMK | 711 | P10721 | |
| EATPDDMSCDYDNMA | 321 | Q6UX15 | |
| SLEEGEPCSMDMSTY | 186 | O15534 | |
| HSMMGDDEDACSDTE | 76 | P41236 | |
| LCSSTMEDSEMDFDS | 16 | Q14686 | |
| YSEDKCDMDSTNMDS | 871 | Q8NFC6 | |
| YDGFMASEDMKTCVD | 1266 | P35555 | |
| SGTDMMLLEDYTSDD | 401 | Q8N6U8 | |
| ETLSSYDDDMDENSM | 791 | Q9BXA9 | |
| SDGGYMDMSKDESVD | 736 | P09619 | |
| CAESMLYHCMSDSEG | 371 | Q7Z699 | |
| ADSMLYHCMSDPEGD | 346 | Q7Z698 | |
| AECYPATMDDMAVDS | 446 | Q13123 | |
| MPFMDESSGSDDDCS | 486 | Q9ULM0 | |
| DYMSGLDDMTDSDSC | 971 | O60315 | |
| SSAYESCMAGMDTSS | 11 | Q99453 |